Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics
February 05, 2020 07:30 ET
|
Vineti
A coalition of strategic industry leaders – including Cardinal Health, Novartis Pharma AG, and Kite, a Gilead Company (Gilead Sciences, Inc.) – joins the company’s existing investor syndicate to...
Vineti and WuXi AppTec Advanced Therapies Collaborate to Simplify Manufacturing Supply Chain for Advanced Therapies
November 06, 2019 09:00 ET
|
Vineti
SAN FRANCISCO and PHILADELPHIA, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Vineti, a leading provider of a digital platform of record for personalized therapies, and WuXi AppTec Advanced Therapies, a...
Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market
September 04, 2019 08:00 ET
|
Vineti; Cryoport, Inc.
SAN FRANCISCO and IRVINE, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Vineti, Inc., and Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) announced a commercial partnership designed to extend end-to-end...
Vineti Awarded as Technology Pioneer by World Economic Forum
July 01, 2019 03:30 ET
|
Vineti
The World Economic Forum has announced its selection of the 56 most promising Technology Pioneers of 2019 who are shaping industries from agriculture and cleantech to modern policing and many...
Vineti Announces New Regional Headquarters in Bethesda, Maryland
May 21, 2019 09:00 ET
|
Vineti
SAN FRANCISCO, May 21, 2019 (GLOBE NEWSWIRE) -- Vineti Inc., the leading software platform of record for personalized therapeutics, today announced the opening of new regional headquarters in...
Vineti and Marker Therapeutics announce strategic partnership to support diverse cell therapy portfolio
April 22, 2019 10:00 ET
|
Vineti
SAN FRANCISCO and HOUSTON, April 22, 2019 (GLOBE NEWSWIRE) -- Vineti Inc., the leading software platform of record for personalized therapeutics, today announced a new partnership to advance and...
Patient Access to Cell and Gene Therapies Improves with CareMetx and Vineti Alliance
March 25, 2019 09:00 ET
|
Vineti
SAN FRANCISCO, CA and BETHESDA, Md., March 25, 2019 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software platform of record for personalized therapies, and OutcomeRx, a new division of CareMetx,...
Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
February 25, 2019 06:15 ET
|
Vineti
SAN FRANCISCO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Vineti Inc, the leading software platform of record for personalized therapeutics, today announced a new partnership to help advance and scale...
Vineti™ to promote greater access to cell and gene therapies, highlight rapid global growth at Phacilitate Leaders World 2019
January 22, 2019 08:00 ET
|
Vineti
MIAMI, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Vineti Inc., the leading digital platform of record for personalized therapies, today announced that CEO Amy DuRoss will chair two expert panels during...
GE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and Delivery
June 20, 2017 07:30 ET
|
Vineti
SAN FRANCISCO, June 20, 2017 (GLOBE NEWSWIRE) -- Vineti, a pioneering cell and gene therapy software and analytics company, today announced it has closed its Series A funding round from GE Ventures,...